Dr. Niyongere is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 South Greene Street S9D04C
Baltimore, MD 21201Phone+1 410-328-8708Fax+1 410-328-6896
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2018
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2012 - 2015
- University of Alabama School of MedicineClass of 2012
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine
Certifications & Licensure
- MD State Medical License 2018 - 2025
- FL State Medical License 2015 - 2019
- IL State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 175 citationsTGF-β Promotes Th17 Cell Development through Inhibition of SOCS3Hongwei Qin, Lanfang Wang, Ting Feng, Charles O. Elson, Sandrine Niyongere
Journal of Immunology. 2009-07-01 - 23 citationsPhase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.Maria R Baer, Aksinija A Kogan, Søren M Bentzen, Tian Mi, Rena G Lapidus
Clinical Cancer Research. 2022-04-01 - 133 citationsMolecular Mechanism of Lipopolysaccharide-Induced SOCS-3 Gene Expression in Macrophages and MicrogliaHongwei Qin, Kevin L. Roberts, Sandrine Niyongere, Yingzi Cong, Charles O. Elson
Journal of Immunology. 2007-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: